|
1
|
Poole H, White S, Blake C, Murphy P and
Bramwell R: Depression in chronic pain patients: Prevalence and
measurement. Pain Pract. 9:173–180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scholich SL, Hallner D, Wittenberg RH,
Hasenbring MI and Rusu AC: The relationship between pain,
disability, quality of life and cognitive-behavioural factors in
chronic back pain. Disabil Rehabil. 34:1993–2000. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hassett AL, Aquino JK and Ilgen MA: The
risk of suicide mortality in chronic pain patients. Curr Pain
Headache Rep. 18:4362014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hawker GA, Gignac MA, Badley E, Davis AM,
French MR, Li Y, Perruccio AV, Power JD, Sale J and Lou W: A
longitudinal study to explain the pain-depression link in older
adults with osteoarthritis. Arthritis Care Res (Hoboken).
63:1382–1390. 2011. View Article : Google Scholar
|
|
5
|
Emery PC, Wilson KG and Kowal J: Major
depressive disorder and sleep disturbance in patients with chronic
pain. Pain Res Manag. 19:35–41. 2014. View Article : Google Scholar :
|
|
6
|
Lin MC, Guo HR, Lu MC, Livneh H, Lai NS
and Tsai TY: Increased risk of depression in patients with
rheumatoid arthritis: A seven-year population-based cohort study.
Clinics (Sao Paulo). 70:91–96. 2015. View Article : Google Scholar
|
|
7
|
Gameroff MJ and Olfson M: Major depressive
disorder, somatic pain, and health care costs in an urban primary
care practice. J Clin Psychiatry. 67:1232–1239. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li JX: Pain and depression comorbidity: A
preclinical perspective. Behav Brain Res. 276:92–98. 2015.
View Article : Google Scholar
|
|
9
|
Yalcin I, Barthas F and Barrot M:
Emotional consequences of neuropathic pain: Insight from
preclinical studies. Neurosci Biobehav Rev. 47:154–164. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Devane WA, Dysarz FA III, Johnson MR,
Melvin LS and Howlett AC: Determination and characterization of a
cannabinoid receptor in rat brain. Mol Pharmacol. 34:605–613.
1988.PubMed/NCBI
|
|
11
|
Matsuda LA, Lolait SJ, Brownstein MJ,
Young AC and Bonner TI: Structure of a cannabinoid receptor and
functional expression of the cloned cDNA. Nature. 346:561–564.
1990. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Devane WA, Hanus L, Breuer A, Pertwee RG,
Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and
Mechoulam R: Isolation and structure of a brain constituent that
binds to the cannabinoid receptor. Science. 258:1946–1949. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mechoulam R, Ben-Shabat S, Hanus L,
Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR,
Compton DR, et al: Identification of an endogenous 2-monoglyceride,
present in canine gut, that binds to cannabinoid receptors. Biochem
Pharmacol. 50:83–90. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sugiura T, Kondo S, Sukagawa A, Nakane S,
Shinoda A, Itoh K, Yamashita A and Waku K: 2-Arachidonoylglycerol:
A possible endogenous cannabinoid receptor ligand in brain. Biochem
Biophys Res Commun. 215:89–97. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leggett JD, Aspley S, Beckett SR, D'Antona
AM and Kendall DA and Kendall DA: Oleamide is a selective
endogenous agonist of rat and human CB1 cannabinoid receptors. Br J
Pharmacol. 141:253–262. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Porter AC, Sauer JM, Knierman MD, Becker
GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB,
et al: Characterization of a novel endocannabinoid, virodhamine,
with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther.
301:1020–1024. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hanus L, Abu-Lafi S, Fride E, Breuer A,
Vogel Z, Shalev DE, Kustanovich I and Mechoulam R: 2-arachidonyl
glyceryl ether, an endogenous agonist of the cannabinoid CB1
receptor. Proc Natl Acad Sci USA. 98:3662–3665. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang SM, Bisogno T, Trevisani M,
Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey
JF, Chu CJ, et al: An endogenous capsaicin-like substance with high
potency at recombinant and native vanilloid VR1 receptors. Proc
Natl Acad Sci USA. 99:8400–8405. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pertwee RG: Targeting the endocannabinoid
system with cannabinoid receptor agonists: Pharmacological
strategies and therapeutic possibilities. Philos Trans R Soc Lond B
Biol Sci. 367:3353–3363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Starowicz K and Di Marzo V:
Non-psychotropic analgesic drugs from the endocannabinoid system:
'magic bullet' or 'multiple-target' strategies? Eur J Pharmacol.
716:41–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sastre-Garriga J, Vila C, Clissold S and
Montalban X: THC and CBD oromucosal spray (Sativex®) in
the management of spasticity associated with multiple sclerosis.
Expert Rev Neurother. 11:627–637. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang T, Collet JP, Shapiro S and Ware MA:
Adverse effects of medical cannabinoids: A systematic review. CMAJ.
178:1669–1678. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Toth C, Mawani S, Brady S, Chan C, Liu C,
Mehina E, Garven A, Bestard J and Korngut L: An enriched-enrolment,
randomized withdrawal, flexible-dose, double-blind,
placebo-controlled, parallel assignment efficacy study of nabilone
as adjuvant in the treatment of diabetic peripheral neuropathic
pain. Pain. 153:2073–2082. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Di Marzo V, Fontana A, Cadas H, Schinelli
S, Cimino G, Schwartz JC and Piomelli D: Formation and inactivation
of endogenous cannabinoid anandamide in central neurons. Nature.
372:686–691. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sugiura T, Kondo S, Sukagawa A, Tonegawa
T, Nakane S, Yamashita A and Waku K: Enzymatic synthesis of
anandamide, an endogenous cannabinoid receptor ligand, through
N-acylphosphatidylethanolamine pathway in testis: Involvement of
Ca(2+)-dependent transacylase and phosphodiesterase activities.
Biochem Biophys Res Commun. 218:113–117. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cravatt BF, Giang DK, Mayfield SP, Boger
DL, Lerner RA and Gilula NB: Molecular characterization of an
enzyme that degrades neuromodulatory fatty-acid amides. Nature.
384:83–87. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blankman JL, Simon GM and Cravatt BF: A
comprehensive profile of brain enzymes that hydrolyze the
endocannabinoid 2-arachidonoylglycerol. Chem Biol. 14:1347–1356.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kozak KR, Rowlinson SW and Marnett LJ:
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to
glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem.
275:33744–33749. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
van der Stelt M, van Kuik JA, Bari M, van
Zadelhoff G, Leeflang BR, Veldink GA, Finazzi-Agrò A, Vliegenthart
JF and Maccarrone M: Oxygenated metabolites of anandamide and
2-arachidonoylglycerol: Conformational analysis and interaction
with cannabinoid receptors, membrane transporter, and fatty acid
amide hydrolase. J Med Chem. 45:3709–3720. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Munro S, Thomas KL and Abu-Shaar M:
Molecular characterization of a peripheral receptor for
cannabinoids. Nature. 365:61–65. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maldonado R, Valverde O and Berrendero F:
Involvement of the endocannabinoid system in drug addiction. Trends
Neurosci. 29:225–232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pertwee RG: Receptors and channels
targeted by synthetic cannabinoid receptor agonists and
antagonists. Curr Med Chem. 17:1360–1381. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim J and Li Y: Chronic activation of CB2
cannabinoid receptors in the hippocampus increases excitatory
synaptic transmission. J Physiol. 593:871–886. 2015. View Article : Google Scholar :
|
|
34
|
Overton HA, Babbs AJ, Doel SM, Fyfe MC,
Gardner LS, Griffin G, Jackson HC, Procter MJ, Rasamison CM,
Tang-Christensen M, et al: Deorphanization of a G protein-coupled
receptor for oleoylethanolamide and its use in the discovery of
small-molecule hypophagic agents. Cell Metab. 3:167–175. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun Y, Alexander SP, Kendall DA and
Bennett AJ: Cannabinoids and PPARalpha signalling. Biochem Soc
Trans. 34:1095–1097. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ryberg E, Larsson N, Sjögren S, Hjorth S,
Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T and
Greasley PJ: The orphan receptor GPR55 is a novel cannabinoid
receptor. Br J Pharmacol. 152:1092–1101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fowler CJ: Anandamide uptake explained?
Trends Pharmacol Sci. 33:181–185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jhaveri MD, Richardson D and Chapman V:
Endocannabinoid metabolism and uptake: Novel targets for
neuropathic and inflammatory pain. Br J Pharmacol. 152:624–632.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Woodward DF, Carling RW, Cornell CL, Fliri
HG, Martos JL, Pettit SN, Liang Y and Wang JW: The pharmacology and
therapeutic relevance of endocannabinoid derived cyclo-oxygenase
(COX)-2 products. Pharmacol Ther. 120:71–80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Basbaum AI, Bautista DM, Scherrer G and
Julius D: Cellular and molecular mechanisms of pain. Cell.
139:267–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Todd AJ: Neuronal circuitry for pain
processing in the dorsal horn. Nat Rev Neurosci. 11:823–836. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fitzgibbon M, Finn DP and Roche M: High
times for painful blues: The endocannabinoid system in
pain-depression comorbidity. Int J Neuropsychopharmacol.
19:192015.
|
|
43
|
Richardson D, Pearson RG, Kurian N, Latif
ML, Garle MJ, Barrett DA, Kendall DA, Scammell BE, Reeve AJ and
Chapman V: Characterisation of the cannabinoid receptor system in
synovial tissue and fluid in patients with osteoarthritis and
rheumatoid arthritis. Arthritis Res Ther. 10:R432008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kaufmann I, Hauer D, Huge V, Vogeser M,
Campolongo P, Chouker A, Thiel M and Schelling G: Enhanced
anandamide plasma levels in patients with complex regional pain
syndrome following traumatic injury: A preliminary report. Eur Surg
Res. 43:325–329. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hill MN and Gorzalka BB: Is there a role
for the endocannabinoid system in the etiology and treatment of
melancholic depression? Behav Pharmacol. 16:333–352. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Koethe D, Llenos IC, Dulay JR, Hoyer C,
Torrey EF, Leweke FM and Weis S: Expression of CB1 cannabinoid
receptor in the anterior cingulate cortex in schizophrenia, bipolar
disorder, and major depression. J Neural Transm Vienna.
114:1055–1063. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Monteleone P, Bifulco M, Maina G,
Tortorella A, Gazzerro P, Proto MC, Di Filippo C, Monteleone F,
Canestrelli B and Buonerba G: Investigation of CNR1 and FAAH
endocannabinoid gene polymorphisms in bipolar disorder and major
depression. Pharmacol Res. 61:400–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Minocci D, Massei J, Martino A, Milianti
M, Piz L, Di Bello D, Sbrana A, Martinotti E, Rossi AM and Nieri P:
Genetic association between bipolar disorder and 524A>C
(Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid
receptor. J Affect Disord. 134:427–430. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Domschke K, Dannlowski U, Ohrmann P,
Lawford B, Bauer J, Kugel H, Heindel W, Young R, Morris P, Arolt V,
et al: Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant
treatment response and emotion processing in major depression. Eur
Neuropsychopharmacol. 18:751–759. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
La Porta C, Bura SA, Llorente-Onaindia J,
Pastor A, Navarrete F, García-Gutiérrez MS, De la Torre R,
Manzanares J, Monfort J and Maldonado R: Role of the
endocannabinoid system in the emotional manifestations of
osteoarthritis pain. Pain. 156:2001–2012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Woolridge E, Barton S, Samuel J, Osorio J,
Dougherty A and Holdcroft A: Cannabis use in HIV for pain and other
medical symptoms. J Pain Symptom Manage. 29:358–367. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Maida V, Ennis M, Irani S, Corbo M and
Dolzhykov M: Adjunctive nabilone in cancer pain and symptom
management: A prospective observational study using propensity
scoring. J Support Oncol. 6:119–124. 2008.PubMed/NCBI
|
|
53
|
Skrabek RQ, Galimova L, Ethans K and Perry
D: Nabilone for the treatment of pain in fibromyalgia. J Pain.
9:164–173. 2008. View Article : Google Scholar
|
|
54
|
Weber J, Schley M, Casutt M, Gerber H,
Schuepfer G, Rukwied R, Schleinzer W, Ueberall M and Konrad C:
Tetrahydrocannabinol (Delta 9-THC) treatment in chronic central
neuropathic pain and fibromyalgia patients: Results of a
multicenter survey. Anesthesiol Res Pract.
2009:8272902009.PubMed/NCBI
|
|
55
|
Schley M, Legler A, Skopp G, Schmelz M,
Konrad C and Rukwied R: Delta-9-THC based monotherapy in
fibromyalgia patients on experimentally induced pain, axon reflex
flare, and pain relief. Curr Med Res Opin. 22:1269–1276. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Whiting PF, Wolff RF, Deshpande S, Di
Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K,
Ryder S, Schmidlkofer S, Westwood M and Kleijnen J: Cannabinoids
for medical use: A systematic review and meta-analysis. JAMA.
313:2456–2473. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Williamson EM and Evans FJ: Cannabinoids
in clinical practice. Drugs. 60:1303–1314. 2000. View Article : Google Scholar
|
|
58
|
Lee MC, Ploner M, Wiech K, Bingel U,
Wanigasekera V, Brooks J, Menon DK and Tracey I: Amygdala activity
contributes to the dissociative effect of cannabis on pain
perception. Pain. 154:124–134. 2013. View Article : Google Scholar : PubMed/NCBI
|
